Continental Chemicals (BSE 506935)₹55.000.00%Software Products
In the Mar 2026 quarter (standalone), Continental Chemicals reported sales of ₹0.08 Cr, up 14.3% from Mar 2025, and net profit of ₹0.11 Cr, down 42.1% year on year. For the year to Mar 2026, sales were ₹0.27 Cr and net profit ₹0.50 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.22 | 0.06 | 0.12 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 |
| Expenses | 0.23 | 0.21 | 0.25 | 0.20 | 0.24 | 0.32 | 0.28 | 0.19 | 0.22 | 0.25 | 0.26 | 0.24 |
| Operating Profit | 0.00 | −0.14 | −0.12 | −0.13 | −0.17 | −0.24 | −0.20 | −0.11 | −0.14 | −0.17 | −0.18 | −0.15 |
| OPM % | −4.7% | −300.0% | −118.1% | −279.9% | −360.0% | −416.6% | −349.9% | −199.9% | −250.0% | −299.9% | −316.6% | −228.5% |
| Other Income | 0.20 | 0.30 | 0.35 | 0.31 | 0.34 | 0.31 | 0.39 | 0.33 | 0.34 | 0.36 | 0.37 | 0.37 |
| Interest | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Depreciation | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 |
| Profit before tax | 0.16 | 0.13 | 0.19 | 0.16 | 0.13 | 0.03 | 0.15 | 0.20 | 0.17 | 0.15 | 0.15 | 0.15 |
| Tax % | 26.7% | 8.3% | 5.6% | 20.0% | 8.4% | 0.0% | 35.7% | 0.0% | 12.5% | 21.5% | 7.2% | 14.3% |
| Net Profit | 0.10 | 0.11 | 0.17 | 0.11 | 0.10 | 0.02 | 0.09 | 0.19 | 0.13 | 0.11 | 0.12 | 0.11 |
| EPS (Rs) | 0.50 | 0.54 | 0.81 | 0.54 | 0.50 | 0.14 | 0.45 | 0.90 | 0.63 | 0.54 | 0.59 | 0.54 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.50 | 0.61 | 0.62 | 0.20 | 0.32 | 0.20 | 0.49 | 0.45 | 0.43 | 0.23 | 0.27 | 0.29 |
| Expenses | 0.73 | 0.87 | 0.87 | 0.94 | 0.90 | 0.68 | 0.85 | 0.89 | 0.86 | 0.99 | 0.94 | 0.97 |
| Operating Profit | −0.22 | −0.25 | −0.24 | −0.73 | −0.57 | −0.47 | −0.35 | −0.43 | −0.42 | −0.75 | −0.66 | −0.64 |
| OPM % | −46.9% | −43.3% | −41.0% | −389.4% | −187.0% | −252.6% | −74.9% | −99.9% | −102.3% | −345.4% | −257.6% | −220.7% |
| Other Income | 0.47 | 0.40 | 0.37 | 1.13 | 0.87 | 0.78 | 0.57 | 0.84 | 1.14 | 1.34 | 1.43 | 1.44 |
| Interest | 0.02 | 0.02 | 0.02 | 0.03 | 0.06 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.08 |
| Depreciation | 0.06 | 0.06 | 0.06 | 0.06 | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 | 0.06 | 0.11 | 0.08 |
| Profit before tax | 0.16 | 0.06 | 0.06 | 0.30 | 0.17 | 0.17 | 0.08 | 0.28 | 0.62 | 0.49 | 0.60 | 0.62 |
| Tax % | 13.3% | 40.0% | 40.0% | −13.8% | 50.0% | 12.5% | 14.3% | 11.1% | 13.2% | 8.3% | 11.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.12 | 0.03 | 0.02 | 0.33 | 0.07 | 0.13 | 0.05 | 0.24 | 0.51 | 0.43 | 0.50 | 0.47 |
| EPS (Rs) | — | — | — | — | 0.37 | 0.63 | 0.28 | 1.12 | 2.32 | 1.97 | 2.28 | 2.30 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 |
| Reserves | 0.31 | 0.45 | 0.50 | 0.54 | 0.88 | 1.33 | 1.50 | 1.57 | 1.83 | 2.35 | 2.79 | 3.31 |
| Borrowings | 0.20 | 0.17 | 0.14 | 0.14 | 0.14 | 0.27 | 0.21 | 0.15 | 0.15 | 0.03 | 0.03 | 0.03 |
| Other Liabilities | 1.13 | 0.99 | 1.03 | 1.11 | 0.88 | 0.85 | 0.91 | 0.96 | 0.86 | 0.95 | 0.98 | 1.06 |
| Total Liabilities | 2.65 | 2.62 | 2.68 | 2.80 | 2.91 | 4.71 | 4.88 | 4.94 | 5.10 | 5.59 | 6.06 | 6.66 |
| Fixed Assets | 2.06 | 1.99 | 1.92 | 1.87 | 1.81 | 1.96 | 1.87 | 1.79 | 1.71 | 2.50 | 2.60 | 2.57 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.59 | 0.63 | 0.76 | 0.93 | 1.10 | 2.75 | 3.01 | 3.15 | 3.39 | 3.09 | 3.46 | 4.09 |
| Trade receivables | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.06 | 0.05 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & equivalents | 0.06 | 0.01 | 0.02 | 0.12 | 0.09 | 1.76 | 2.06 | 2.15 | 2.43 | 2.65 | 2.97 | 3.62 |
| Total Assets | 2.65 | 2.62 | 2.68 | 2.80 | 2.91 | 4.71 | 4.88 | 4.94 | 5.10 | 5.59 | 6.06 | 6.66 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.23 | 0.00 | 0.00 | 0.10 | 0.00 | −0.93 | −0.69 | 0.06 | −0.17 | 0.91 | −0.09 | −0.11 |
| Cash from investing activity | −0.26 | 0.00 | −0.01 | 0.00 | 0.00 | −0.17 | 0.29 | 0.10 | 0.11 | −0.68 | 0.02 | 0.11 |
| Cash from financing activity | 0.09 | −0.03 | 0.02 | 0.00 | 0.00 | 1.64 | −0.09 | −0.09 | −0.02 | −0.15 | −0.03 | −0.03 |
| Net cash flow | 0.07 | −0.06 | 0.02 | 0.10 | −0.04 | 0.53 | −0.51 | 0.09 | −0.10 | 0.08 | −0.12 | −0.06 |
| Capex | 0.31 | 0.00 | 0.00 | 0.02 | 0.02 | 0.24 | 0.00 | 0.02 | 0.00 | 0.28 | 0.18 | 0.12 |
| Free cash flow | −0.07 | −0.02 | 0.00 | 0.11 | −0.03 | −1.18 | −0.71 | 0.07 | −0.19 | 0.66 | −0.28 | −0.23 |
| CFO / OP % | −133.0% | 4.0% | 0.0% | −56.0% | −8.0% | 152.0% | 154.0% | −36.0% | 39.0% | −228.0% | −1.0% | 12.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 0 | 36 | 0 | 59 | 77 | 15 | 0 | 0 | 0 | 0 |
| Cash conversion cycle | 0 | 0 | 0 | 36 | 0 | 59 | 77 | 15 | 0 | 0 | 0 | 0 |
| Working capital days | −892 | −709 | −518 | −587 | −1,250 | −743 | −1,442 | −541 | −557 | −679 | −1,262 | −1,194 |
| ROCE % | 15.8% | 10.2% | 3.7% | 3.6% | 16.7% | 7.1% | 5.1% | 2.8% | 7.3% | 14.7% | 10.7% | 11.8% |
For the Mar 2026 quarter, Continental Chemicals reported sales of ₹0.08 Cr, up 14.3% year on year and net profit of ₹0.11 Cr, down 42.1% year on year. The operating margin was −228.5%.
Continental Chemicals' sales for the year to Mar 2026 were ₹0.27 Cr; over the last twelve months they were ₹0.29 Cr.
Net profit for the year to Mar 2026 was ₹0.50 Cr, and ₹0.47 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.30.
Continental Chemicals reported borrowings of ₹0.03 Cr at Mar 2026, against cash and equivalents of ₹3.62 Cr.
Cash from operations was −₹0.11 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.23 Cr.